# OnCo record paper-hudson-phillips-expanded-germline-testing-clin-breast-cancer-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-hudson-phillips-expanded-germline-testing-clin-breast-cancer-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-hudson-phillips-expanded-germline-testing-clin-breast-cancer-2026" ;
  schema:name "The impact of expanded access to germline high penetrance genetic testing for women with a new diagnosis of invasive breast cancer or high-grade DCIS"@en ;
  schema:description "Offering high-penetrance gene testing to 576 newly diagnosed women regardless of the NHS criteria found an inherited variant in 3.6%, a quarter of whom would have been ineligible, and results in hand before surgery changed the operation chosen."@en ;
  schema:url <https://onco.cc/key-papers/paper-hudson-phillips-expanded-germline-testing-clin-breast-cancer-2026/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.clbc.2026.07.031>, <https://pubmed.ncbi.nlm.nih.gov/42659730/> ;
  schema:sameAs <https://doi.org/10.1016/j.clbc.2026.07.031> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Hudson-Phillips SP, Nanda A, Attia M, et al." ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-cancer/> ;
  onco:technologies <https://onco.cc/technologies/germline-testing/> ;
  onco:targets <https://onco.cc/targets/brca/>, <https://onco.cc/targets/palb2/> ;
  onco:institutions <https://onco.cc/institutions/royal-marsden/> ;
  onco:terms <https://onco.cc/terms/gbrca-mutation/> ;
  onco:journals <https://onco.cc/journals/clinical-breast-cancer/> .